Welcome to chemicalbook!
400-158-6606
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook >> CAS DataBase List >> Sitafloxacin

Sitafloxacin

Sitafloxacin price.
  • $88 - $11880
  • Product name: Sitafloxacin
  • CAS: 127254-12-0
  • MF: C19H18ClF2N3O3
  • MW: 409.81
  • EINECS:1308068-626-2
  • MDL Number:MFCD00903720
  • Synonyms:spifloxacin;7-[(4S)-4-Amino-6-azaspiro[2.4]heptan-6-yl]-8-chloro-6-fluoro-1-[(2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid;3-Quinolinecarboxylic acid, 7-[(7S)-7-aMino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-;Sitafloxacin anhydrous;7-((S)-7-Amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4;Sitafloxacfn;Sitfloxacfn;Sitafloxacin-d4
7 prices
Selected condition:
Brand
  • American Custom Chemicals Corporation
  • Chemenu
  • Crysdot
  • Matrix Scientific
Package
  • 5mg
  • 10mg
  • 50mg
  • 1G
  • 5g
  • ManufacturerAmerican Custom Chemicals Corporation
  • Product numberAPI0006381
  • Product descriptionSITAFLOXACIN 95.00%
  • Packaging1G
  • Price$3405.15
  • Updated2021-12-16
  • Buy
  • ManufacturerChemenu
  • Product numberCM139116
  • Product description7-((S)-7-Amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid 98%
  • Packaging50mg
  • Price$468
  • Updated2021-12-16
  • Buy
  • ManufacturerCrysdot
  • Product numberCD31004021
  • Product descriptionSitafloxacin 98+%
  • Packaging5mg
  • Price$88
  • Updated2021-12-16
  • Buy
  • ManufacturerCrysdot
  • Product numberCD31004021
  • Product descriptionSitafloxacin 98+%
  • Packaging10mg
  • Price$166
  • Updated2021-12-16
  • Buy
  • ManufacturerCrysdot
  • Product numberCD31004021
  • Product descriptionSitafloxacin 98+%
  • Packaging50mg
  • Price$501
  • Updated2021-12-16
  • Buy
  • ManufacturerMatrix Scientific
  • Product number120731
  • Product description7-((S)-7-Amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid 97%
  • Packaging1g
  • Price$3960
  • Updated2021-12-16
  • Buy
  • ManufacturerMatrix Scientific
  • Product number120731
  • Product description7-((S)-7-Amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid 97%
  • Packaging5g
  • Price$11880
  • Updated2021-12-16
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
American Custom Chemicals Corporation API0006381 SITAFLOXACIN 95.00% 1G $3405.15 2021-12-16 Buy
Chemenu CM139116 7-((S)-7-Amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid 98% 50mg $468 2021-12-16 Buy
Crysdot CD31004021 Sitafloxacin 98+% 5mg $88 2021-12-16 Buy
Crysdot CD31004021 Sitafloxacin 98+% 10mg $166 2021-12-16 Buy
Crysdot CD31004021 Sitafloxacin 98+% 50mg $501 2021-12-16 Buy
Matrix Scientific 120731 7-((S)-7-Amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid 97% 1g $3960 2021-12-16 Buy
Matrix Scientific 120731 7-((S)-7-Amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid 97% 5g $11880 2021-12-16 Buy

Properties

Boiling point :629.2±55.0 °C(Predicted)
Density :1.63±0.1 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: slightly soluble; DMSO: slightly soluble; Methanol: slightly soluble
form :A crystalline solid
pka :6.39±0.50(Predicted)
CAS DataBase Reference :127254-12-0(CAS DataBase Reference)

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H302 Harmful if swallowed Acute toxicity,oral Category 4 Warning GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 Causes skin irritation Skin corrosion/irritation Category 2 Warning GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 Causes serious eye irritation Serious eye damage/eye irritation Category 2A Warning GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 May cause respiratory irritation Specific target organ toxicity, single exposure;Respiratory tract irritation Category 3 Warning GHS hazard pictograms
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P264 Wash hands thoroughly after handling.
P264 Wash skin thouroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P271 Use only outdoors or in a well-ventilated area.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P301+P312 IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P302+P352 IF ON SKIN: wash with plenty of soap and water.
P304+P340 IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P330 Rinse mouth.
P332+P313 IF SKIN irritation occurs: Get medical advice/attention.
P337+P313 IF eye irritation persists: Get medical advice/attention.
P362 Take off contaminated clothing and wash before reuse.
P403+P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
P501 Dispose of contents/container to..…

Description

Sitafloxacin hydrate is the newest member (fourth generation) of the fluoroquinolone family of antibiotics that exhibits broad spectrum activity against many Gram-positive, Gramnegative, and anaerobic clinical isolates, including strains resistant to other fluoroquinolones. Since the launch of the first fluoroquinolone norfloxacin (patented in 1978), 20 other versions have made it to market with ciprofloxacin and levofloxacin experiencing the most prevalent usage. The mechanism of action involves inhibition of bacterial type II topoisomerases, both DNA gyrase and topoisomerase IV. By inhibiting these enzymes and preventing DNA supercoiling, cell division is disrupted leading to cell death. In Gram-negative bacteria, the primary target appears to be gyrase, whereas topoisomerase IV is involved in Gram-positive bacteria. Dual inhibition is attractive for widespread activity and avoidance of resistance as both encoding genes would have to acquire mutations.

Related product price